Retaglutide is a novel GLP-1 receptor agonist currently under investigation for the control of metabolic disorders. This therapy works by enhancing the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring https://tedhbpt213364.blogs-service.com/69975097/retaglutide-a-promising-glp-1-receptor-agonist